NR4A1 and breast carcinoma: In the hormone receptor-negative subgroup, only lymphovascular invasion was associated with poor prognosis of patients (p = 0.033) and Oct4 expression did not show prognostic significance in this subgroup of breast cancer (p = 0.115).